Concepedia

Norbert Hilf

NH

25

Publications

4.2K

Citations

19

H-Index

1999

Active since

Affiliations

University of Tübingen(Current)

Immatics Biotechnologies (Germany)

Leiden University Medical Center

The University of Texas MD Anderson Cancer Center

Heidelberg University

Norbert Hilf is an author at University of Tübingen specializing in medicine, immunology, and immunotherapy.

ORCID

Top concepts

Publications per year

1999–2025

25

Publications

25

Actively personalized vaccination trial for newly diagnosed glioblastoma

Norbert Hilf, Sabrina Kuttruff-Coqui, Katrin Frenzel et al. · Nature · 2018 · 897 citations

, , +6

Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival

Steffen Walter, Toni Weinschenk, Arnulf Stenzl et al. · Nature Medicine · 2012 · 777 citations · Full text

, , +12

The Endoplasmic Reticulum-resident Heat Shock Protein Gp96 Activates Dendritic Cells via the Toll-like Receptor 2/4 Pathway

R. Martin Vabulas, Sibylla Braedel, Norbert Hilf et al. · Journal of Biological Chemistry · 2002 · 483 citations · Full text

The heat shock protein gp96 induces maturation of dendritic cells and down-regulation of its receptor

Harpreet Singh‐Jasuja, Hans Ulrich Scherer, Norbert Hilf et al. · European Journal of Immunology · 2000 · 370 citations · Full text

Cross-Presentation of Glycoprotein 96–Associated Antigens on Major Histocompatibility Complex Class I Molecules Requires Receptor-Mediated Endocytosis

Harpreet Singh‐Jasuja, René E. M. Toes, Pieter Spee et al. · The Journal of Experimental Medicine · 1999 · 349 citations · Full text

Rows per page

1–5 of 25